Baker Bros. Advisors LP Relmada Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$16.93 - $26.82 $4.98 Million - $7.89 Million
294,117 Added 146.33%
495,113 $11.2 Million
Q3 2021

Nov 15, 2021
BUY
$21.86 - $34.77 $2.72 Million - $4.33 Million
124,396 Added 162.4%
200,996 $5.27 Million
Q2 2021

Aug 16, 2021
BUY
$29.55 - $39.15 $2.26 Million - $3 Million
76,600 New
76,600 $2.45 Million

Others Institutions Holding RLMD

# of Institutions
81
Shares Held
12.3M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $77.8M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email